Concord Healthcare’s Shareholding Boost by Controlling Shareholder

Concord Medical Services ( (CCM) ) has issued an announcement.

On May 12, 2025, Concord Healthcare Group Co., Ltd., a subsidiary of Concord Medical Services Holdings Limited, announced that its controlling shareholder, Medstar (Shanghai) Enterprise Management Co., LTD, increased its shareholding by purchasing 95,400 H shares from the open market. This purchase represents approximately 0.01% of the total issued shares of Concord Healthcare. This move follows the listing of Concord Healthcare’s H shares on the Hong Kong Stock Exchange on January 9, 2024, and signifies a strategic consolidation of ownership, potentially strengthening the company’s market position.

Spark’s Take on CCM Stock

According to Spark, TipRanks’ AI Analyst, CCM is a Underperform.

Concord Medical Services’ stock faces significant challenges primarily due to its poor financial performance, characterized by declining revenue and high leverage. While technical indicators show some positive momentum, the company’s negative P/E ratio and lack of dividends make it an unattractive investment for those seeking value or income. The absence of earnings call data or significant corporate events leaves the financial issues as the predominant factor impacting the stock score.

To see Spark’s full report on CCM stock, click here.

More about Concord Medical Services

Concord Medical Services Holdings Limited operates within the healthcare industry, focusing on providing medical services and healthcare management. It is known for its involvement in the operation and management of radiotherapy and diagnostic imaging centers across China.

Average Trading Volume: 34,130

Technical Sentiment Signal: Buy

Current Market Cap: $35.6M

For detailed information about CCM stock, go to TipRanks’ Stock Analysis page.